StonvexLoading…
StonvexStonvexStonvexCore line items from NOBH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-11-01 | Annual 2024 2024-11-02 | Annual 2023 2023-11-04 | Annual 2022 2022-11-05 |
|---|---|---|---|---|
Revenue | $52.67M | $51.93M | $63.32M | $51.52M |
Operating Income | $10.04M | $9.58M | $13.40M | $8.43M |
Net Income | $8.45M | $8.61M | $10.90M | $7.23M |
EPS (Diluted) | $2.58 | $2.63 | $3.27 | $2.10 |
Total Assets | $67.15M | $66.60M | $65.70M | $62.36M |
Total Liabilities | $6.43M | $10.00M | Not available | $14.44M |
Cash & Equivalents | $13.23M | $13.52M | $13.88M | $16.65M |
Free Cash Flow OCF − CapEx | $3.98M | $6.87M | $9.62M | $-9.08M |
Shares Outstanding | 3.25M | 3.27M | 3.27M | 3.37M |